Vext Science の収益と比較して、Eric Offenberger の報酬はどのように変化したか？
日付	総報酬	給与	会社業績
Jun 30 2024	n/a	n/a	-US$7m
Mar 31 2024	n/a	n/a	-US$2m
Dec 31 2023	US$456k	US$306k	US$4m
Sep 30 2023	n/a	n/a	US$5m
Jun 30 2023	n/a	n/a	US$7m
Mar 31 2023	n/a	n/a	US$9m
Dec 31 2022	US$448k	US$360k	US$11m
Sep 30 2022	n/a	n/a	US$6m
Jun 30 2022	n/a	n/a	US$6m
Mar 31 2022	n/a	n/a	US$6m
Dec 31 2021	US$414k	US$300k	US$5m
Sep 30 2021	n/a	n/a	US$5m
Jun 30 2021	n/a	n/a	US$5m
Mar 31 2021	n/a	n/a	US$4m
Dec 31 2020	US$219k	US$219k	US$2m

報酬と市場: Ericの総報酬 ($USD 455.74K ) は、 Canadian市場 ($USD 177.35K ) の同規模の企業の平均を上回っています。

報酬と収益: Ericの報酬は増加しましたが、会社は利益を上げていません。

CEO（最高経営責任者

Eric Offenberger

5.8yrs

在職期間

US$455,739

報酬

Mr. Eric J. Offenberger has been the Chief Executive Officer and President of Vext Science, Inc. since February 18, 2020 and has been its Director since February 14, 2020 and serves as its Chief Operating...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Jason Nguyen	Founder & Executive Chairman	less than a year	US$555.00k	20.08% $ 12.1m
Eric Offenberger	CEO, COO	5.8yrs	US$455.74k	データなし
Trevor Smith	Chief Financial Officer	1.1yrs	US$65.39k	0.17% $ 101.4k
Nalee Pham	Company Secretary	1.1yrs	US$121.73k	データなし
Jonathan Ross	Investor Relations Officer	no data	データなし	データなし

1.1yrs

平均在職期間

経験豊富な経営陣: VEXTの経営陣は経験豊富とはみなされません ( 0.8年の平均在職年数)。これは新しいチームを示唆しています。

取締役

名称	ポジション	在職期間	報酬	所有権
Jason Nguyen	Founder & Executive Chairman	less than a year	US$555.00k	20.08% $ 12.1m
Eric Offenberger	CEO, COO	4.6yrs	US$455.74k	データなし
Mark Opzoomer	Independent Director	2.6yrs	US$84.75k	0.86% $ 518.5k
David Johns	Director	1.8yrs	US$46.15k	0.43% $ 259.2k
Scott Hill	Board Advisor	5yrs	データなし	データなし
Jeffery Yarger	Board Advisor	4.9yrs	データなし	データなし
Terry Creighton	Independent Director	less than a year	データなし	データなし
Spiro Phanos	Director	less than a year	データなし	0.073% $ 44.0k

2.2yrs

平均在職期間

経験豊富なボード: VEXTの取締役会は経験豊富ではない ( 1.9年の平均在任期間) ため、新しい取締役会が必要であると考えられます。

Vext Science マネジメント

マネジメント 基準チェック /04

主要情報

経営陣の近況

Chief Financial Officer recently bought CA$63k worth of stock

Vext Science, Inc. Announces Transition of Jason Thai Nguyen Out of Executive Role

Vext Science, Inc., Annual General Meeting, Dec 15, 2023

Vext Science, Inc. Resigns Stephan Bankosz as Corporate Secretary, Effective August 25, 2023

Less than half of directors are independent

Vext Science, Inc. Announces Board Changes

Recent updates

Second quarter 2024 earnings released: US$0.018 loss per share (vs US$0.004 profit in 2Q 2023)

Vext Science, Inc. to Report Q2, 2024 Results on Aug 20, 2024

Price target increased by 12% to CA$0.75

Take Care Before Jumping Onto Vext Science, Inc. (CSE:VEXT) Even Though It's 30% Cheaper

Chief Financial Officer recently bought CA$63k worth of stock

Vext Science, Inc. to Report Q1, 2024 Results on May 29, 2024

New minor risk - Earnings quality

Vext Science, Inc. to Report Q4, 2023 Results on Apr 25, 2024

New major risk - Shareholder dilution

Vext Science, Inc. Announces Transition of Jason Thai Nguyen Out of Executive Role

There Is A Reason Vext Science, Inc.'s (CSE:VEXT) Price Is Undemanding

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Vext Science, Inc. to Report Q3, 2023 Results on Nov 28, 2023

Vext Science, Inc., Annual General Meeting, Dec 15, 2023

New major risk - Shareholder dilution

Vext Science, Inc. announced that it has received $11.5 million in funding from LLF Financial S.A.

Is Now The Time To Put Vext Science (CSE:VEXT) On Your Watchlist?

Second quarter 2023 earnings: EPS exceeds analyst expectations

Vext Science, Inc. to Report Q2, 2023 Results on Aug 23, 2023

Does Vext Science (CSE:VEXT) Have A Healthy Balance Sheet?

Vext Science, Inc. Resigns Stephan Bankosz as Corporate Secretary, Effective August 25, 2023

First quarter 2023 earnings released: EPS: US$0 (vs US$0.016 in 1Q 2022)

Vext Science, Inc. to Report Q1, 2023 Results on May 25, 2023

Price target increased by 7.2% to CA$1.30

Full year 2022 earnings released: EPS: US$0.079 (vs US$0.036 in FY 2021)

Does Vext Science (CSE:VEXT) Have A Healthy Balance Sheet?

Less than half of directors are independent

Vext Science, Inc. (CNSX:VEXT) entered into agreement to acquire Appalachian Pharm Processing, LLC for $12.5 million.

Vext Science, Inc. Announces Board Changes

Shareholders May Be More Conservative With Vext Science, Inc.'s (CSE:VEXT) CEO Compensation For Now

Price target decreased to CA$1.24

Third quarter 2022 earnings released: EPS: US$0.003 (vs US$0.007 in 3Q 2021)

Less than half of directors are independent

Vext Science, Inc. to Report Q3, 2022 Results on Nov 17, 2022

Price target decreased to CA$1.46

Vext Science, Inc., Annual General Meeting, Dec 15, 2022

We Think Vext Science (CSE:VEXT) Can Stay On Top Of Its Debt

Vext Science Announces Filing of Provisional Patent Application

Sopica Special Opportunities Fund Limited, managed by LLF Financial S.A. acquired a 13.65% stake in Vext Science, Inc. (CNSX:VEXT) from Jason T. Nguyen for $3 million.

Second quarter 2022 earnings released: EPS: US$0.014 (vs US$0.013 in 2Q 2021)

Director recently bought CA$53k worth of stock

Vext Science, Inc. to Report Q2, 2022 Results on Aug 24, 2022

Vext Science, Inc. Announces CFO Transition

First quarter 2022 earnings released

Vext Science, Inc. to Report Q1, 2022 Results on May 30, 2022

Vext Science (CSE:VEXT) Seems To Use Debt Quite Sensibly

Price target decreased to CA$1.84

Less than half of directors are independent

Full year 2021 earnings released: EPS: US$0.036 (vs US$0.023 in FY 2020)

Vext Science, Inc. Announces Executive Changes

Vext Science, Inc. to Report Q4, 2021 Results on Apr 20, 2022

Price target decreased to CA$1.99

Less than half of directors are independent

Vext Science, Inc. Appoints Mark W. Opzoomer as Board of Director

Third quarter 2021 earnings released

Does Vext Science (CSE:VEXT) Have A Healthy Balance Sheet?

Second quarter 2021 earnings released

Is Vext Science (CSE:VEXT) A Risky Investment?

Vext Science, Inc. (CNSX:VEXT) completed the acquisition of a 72,000 square foot industrial facility in Eloy, Arizona.

First quarter 2021 earnings released

Weak Statutory Earnings May Not Tell The Whole Story For Vext Science (CSE:VEXT)

Full year 2020 earnings released

Vext Science, Inc. Announces CFO Changes

New 90-day high: CA$1.54

Vext Science, Inc. has completed a Composite Units Offering in the amount of CAD 18.032 million.

Vext Science, Inc. announced that it has received CAD 1.5624 million in funding

Based On Its ROE, Is Vext Science, Inc. (CSE:VEXT) A High Quality Stock?

New 90-day high: CA$1.13

New 90-day high: CA$0.95

マネジメント基準チェック /04